Clinical trials
Phase 3 Biliary Tract Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Completed | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| 3D Medicines (Sichuan) Co., Ltd. | 1 |
| Akeso | 1 |
| Fudan University | 1 |
| Jazz Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 11 |
| Gallbladder Neoplasms | 3 |
| Cholangiocarcinoma | 2 |
| Bile Duct Neoplasms | 1 |
| Duodenal Neoplasms | 1 |
| Klatskin Tumor | 1 |
| Pancreatic Neoplasms | 1 |
| Pancreatitis, Chronic | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.